2019冠状病毒病首次胸部CT影像表现及其与临床表现的相关性研究

Initial chest CT findings in COVID-19: correlation with clinical features # # 2019冠状病毒病首次胸部CT影像表现及其与临床表现的相关性研究 1 first-author 1 2 3 4 5 6 7 8 1 1 corresp ‡Corresponding Author ‡Corresponding Author †E-mail:zjdxlinbin@zju.edu.cn †E-mail:zjdxlinbin@zju.edu.cn zjdxlinbin@zju.edu.cn Department of Radiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China Department of Radiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China Department of Radiology, Zhejiang Hospital, Hangzhou 310013, China Department of Radiology, Zhejiang Hospital, Hangzhou 310013, China Department of Radiology, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin 541002, China Department of Radiology, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin 541002, China Department of Radiology, Guang’an People Hospital, Guang’an 638000, China Department of Radiology, Guang’an People Hospital, Guang’an 638000, China Department of Radiology, Zhuzhou Central Hospital, Zhuzhou 412007, China Department of Radiology, Zhuzhou Central Hospital, Zhuzhou 412007, China Department of Radiology, Affiliated Hospital of Yan’an University, Yan’an 716000, China Department of Radiology, Affiliated Hospital of Yan’an University, Yan’an 716000, China Department of Radiology, Traditional Chinese Hospital of Ma’anshan, Ma’anshan 243000, China Department of Radiology, Traditional Chinese Hospital of Ma’anshan, Ma’anshan 243000, China Department of Radiology, the Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China Department of Radiology, the Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China Department of Radiology, Neihuang People’s Hospital, Anyang 456300, China Department of Radiology, Neihuang People’s Hospital, Anyang 456300, China In December 2019, coronavirus disease 2019 (COVID-19), a new de novo infectious disease, was first identified in Wuhan, China and quickly spread across China and around the world. The etiology was a novel betacoronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Lu et al., 2020 2020 ). On Mar. 11, 2020, World Health Organization (WHO) characterized COVID-19 as a global pandemic. As of Mar. 22, 2020, over 292 000 confirmed COVID-19 cases have been reported globally. To date, COVID-19, with its high infectivity, has killed more people than severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) combined (Wu and McGoogan, 2020 2020 ). 目的 2 分析2019冠状病毒病(COVID-19)患者首次胸部CT影像表现及其与临床表现(包括发热症状、实验室检查)的相关性. 创新点 2 初步探索COVID-19肺部病灶与临床数据的相关性,对评估COVID-19患者提供一定的依据. 方法 2 纳入2020年1月16日至2020年2月6日入院的36例COVID-19患者,回顾性分析首次胸部CT的影像学表现,包括影像特征、分布模式、累及范围等,并进一步分析其与临床特征(包括发病时间、发热症状、白细胞计数等)的相关性. 结论 2 结果发现,在自然病程中,COVID-19肺部病变与发病时间显著相关,特别是发热症状.COVID-19病变范围与淋巴细胞计数呈负相关,淋巴细胞减少可能是COVID-19进展的标志之一. Coronavirus disease 2019 (COVID-19) Chest computed tomography (CT) Viral pneumonia Lymphopenia 2019冠状病毒病(COVID-19) 胸部CT 发热 淋巴细胞减少 In December 2019, coronavirus disease 2019 (COVID-19), a new de novo infectious disease, was first identified in Wuhan, China and quickly spread across China and around the world. The etiology was a novel betacoronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Lu et al., 2020 2020 ). On Mar. 11, 2020, World Health Organization (WHO) characterized COVID-19 as a global pandemic. As of Mar. 22, 2020, over 292 000 confirmed COVID-19 cases have been reported globally. To date, COVID-19, with its high infectivity, has killed more people than severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) combined (Wu and McGoogan, 2020 2020 ). Researchers are continuing to rigorously document and analyze clinical and radiological findings from laboratory-confirmed COVID-19 patients so that the clinical, laboratorial, and radiological changes in these patients can be better understood (Chen et al., 2020 2020 ; Chung et al., 2020 2020 ; Guan et al., 2020 2020 ; Huang et al., 2020 2020 ; Pan YY et al., 2020 2020 ; Shi et al., 2020 2020 ; Song et al., 2020 2020 ; Wang et al., 2020 2020 ). Records showed that common symptoms include fever and respiratory symptoms including dry cough and sore throat. Laboratory test results showed that lymphopenia is present in most cases and that lung abnormalities usually present as viral pneumonia, similar to other kinds of viral pneumonia (Yin and Wunderink, 2018 2018 ). Computed tomography (CT) scans, as a sensitive modality that detects changes in the lungs, are playing an important role in the evaluation and management of COVID-19 patients. Progressive airspace opacities and multifocal patchy subpleural ground-glass opacifications (GGOs) have been recorded as among the most common initial CT appearances of COVID-19 (Bernheim et al., 2020 2020 ; Shi et al., 2020 2020 ; Zu et al., 2020 2020 ). However, the relationship between CT imaging features and clinical features remains unclear. In this study, we analyze initial chest CT images of patients with COVID-19 to determine the natural history of lung abnormalities and the relation of these characteristics with clinical features. These findings may help researchers and practitioners to more fully understand the clinical course and lung changes prompted by COVID-19 infection and possibly lead to improved methods in public health surveillance and evaluation. Data for this study were taken from records of 36 patients with confirmed COVID-19 who were admitted to hospital from Jan. 16 to Feb. 6, 2020. Demographic and clinical data were obtained from all patients, including severity and time course of symptoms, laboratory results, and patient histories, including exposure. Data for this analysis for each patient included the duration from the onset of symptoms to the initial CT scan, fever measurements (including highest temperature and the duration from fever onset to CT scan), and white blood cell counts. Other blood parameters were not included due to limited data availability. All CT images were reviewed by two experienced radiologists who used scoring method described by Chung et al. ( 2020 2020 ) to evaluate the extent of involvement for each of the five lung lobes. Score 0, signified normality; Score 1, 1%–25% of the total lobe area; Score 2, 26%–50% of the total lobe area; Score 3, 51%–75% of the total lobe area; Score 4, 76%–100% of the total lobe area. The overall lung “CT score” was obtained by summing the five lung lobe scores (range, 0–20). As indicated in Table 1 1 , patients in this study had a median age of 46 years (interquartile range (IQR), 34–55 years). The median interval between onset and initial CT scanning was 4 d with IQR of 2–7 d. Among them, 33 (91.7%) patients presented with fever, and 30 of them (83.3%) experienced fever as the initial symptom. Thirty-one (86.1%) patients had low or middle fever (lower than 39 °C). As three patients did not have fever, the median interval between fever onset and CT scanning was 3 d with IQR of 1–7 d. On admission, 10 patients (27.8%) had leucopenia (white blood cell count < 4×10 9 L −1 ), 20 (55.6%) had lymphopenia (lymphocyte percentage < 20%), and 24 (66.7%) had neutrophilia (neutrophil percentage > 70%). Values are expressed as number (percentage) or median (interquartile range, IQR). CT, computed tomography; WBC, white blood cell Clinical feature Value * * Sex  Men 14 (38.9)  Women 22 (61.1) Age (year) 46 (34–55) Exposure history  Recent travel to Wuhan 24 (66.7)  Exposure to infected patient 7 (19.4)  Unknown exposure 5 (13.9) Fever 33 (91.7)  Highest temperature (°C) 38.3 (37.7–38.9)  <37.3 3 (8.3)  37.3–38.0 14 (38.9)  38.1–39.0 17 (47.2)  >39.0 2 (5.6) Other symptoms  Cough 24 (66.7)  Sputum production 8 (22.2)  Sore throat 11 (30.6)  Chills/rigor 9 (25.0)  Rhinorrhoea 4 (11.1)  Shortness of breath 6 (16.7)  Headache/dizziness 6 (16.7)  Muscle pain/fatigue 15 (41.7)  Diarrhea 1 (2.8) Duration from onset to CT scanning (d) 4 (2–7) Duration from fever onset to CT scanning (d) 3 (1–7) WBC count (×10 9 L −1 ) 5.3 (3.7–7.0)  <4 10 (27.8)  4–10 25 (69.4)  >10 1 (2.8) Neutrophil count (×10 9 L −1 ) 3.7 (2.7–5.4)  <50% 3 (8.3)  50%–70% 9 (25.0)  >70% 24 (66.7) Lymphocyte count (×10 9 L −1 ) 1.0 (0.6–1.2)  <20% 20 (55.6)  20%–40% 11 (30.6)  >40% 5 (13.9) Fig. 1 1 presents the results of correlations between CT score and clinical data. CT scores were positively correlated with age ( r =0.333, P =0.048) and with the duration from onset to CT scanning ( r =0.666, P < 0.001). CT scores correlated well with the duration from fever onset to CT scanning ( r =0.698, P < 0.001), and a marginally significant correlation was observed between CT scores and the highest temperature ( r =0.290, P =0.086). Additionally, CT scores were negatively correlated with the lymphocyte count ( r =−0.495, P =0.002), but positively correlated with the neutrophil count ( r =0.385, P =0.021). The imaging features of lung lesions from early to late stage are showed in the supplementary materials (Document S1 S1 ). Age (a), duration of symptoms (b), duration of fever (c), the highest temperature (d), lymphocyte count (e), and neutrophil count (f). CT, computed tomography In this study, we investigated the initial CT features in COVID-19 patients and correlated results with their clinical features. Viral pneumonia developed in 94.4% of infected patients, presenting with GGO or/and consolidation with a focal or diffuse distribution, findings similar to those previously described (Chung et al., 2020 2020 ; Pan YY et al., 2020 2020 ; Shi et al., 2020 2020 ; Song et al., 2020 2020 ). In addition, the lung involvement was positively correlated with the duration of symptoms in all patients. These lung abnormalities were observed in the initial patient CT images and none necessitated any interventions. Our findings indicate that in the natural progress of SARS-CoV-2 infection, lung lesions become more sever with longer duration of symptoms, results consistent to those of infections just as SARS (Ooi et al., 2003 2003 ). Recent studies have also shown that lung involvement increases rapidly after the onset of symptoms (Bernheim et al., 2020 2020 ; Pan F et al., 2020 2020 ). More than 90% patients with COVID-19 developed fever during the disease course, with 90.9% of these patients exhibiting fever as their first symptom. Similar results were reported in recent studies (Huang et al., 2020 2020 ; Wang et al., 2020 2020 ), as well as in other viral pneumonia caused by coronavirus, such as SARS and MERS (Yin and Wunderink, 2018 2018 ). Wu et al. ( 2020 2020 ) have also documented that the extent of lung lesions has been positively correlated with the duration and degree of fever. To date, there is limited evidence about the pathophysiology about the COVID-19. It was reported that SARS-CoV-2 infection induced increased concentrations of proinflammatory cytokines (interleukin-1β (IL-1β), IL-4, IL-10, interferon-γ (IFN-γ), IFN-γ-inducible protein-10 (IP10), and monocyte chemoattractant protein-1 (MCP1)) (Huang et al., 2020 2020 ) and decreased lymphocytes in patients with COVID-19 (Chen et al., 2020 2020 ; Wang et al., 2020 2020 ). Overactivation of T cells observed in at least one pathological study (Xu et al., 2020 2020 ) suggests that virus particles spread through the respiratory mucosa and infected other cells induced a cytokine storm in the body. This response is thought to have generated a follow on series of immune responses (mainly cellular immune) and caused changes in peripheral white blood cells and immune cells (especially T lymphocytes), in turn resulting in diffuse alveolar damage. Data from both this and one previous study (Wu et al., 2020 2020 ) indicate that there are correlations between degree of lung lesions and observed white blood cell count. The negative correlation between lung involvement and lymphocyte count in peripheral blood ( r =−0.260, P < 0.05) (Wu et al., 2020 2020 ) provided more information that lymphopenia might be the hallmark of the exacerbations of COVID-19. Further studies are necessary to characterize the pathology and pathogenesis in COVID-19, which will help to improve our understanding of the disease. Notably, there were some outlier results in this study in two teenager patients. Both patients did have fever, went to hospital on the first day and third day of onset symptom, respectively, but were admitted with normal CT. Three other patients were admitted with mild lung abnormalities, mild symptoms, and no fever. These suggested that early presentation to the healthcare center for testing helped to diagnose the disease in mild stage and allowed for better prognosis. This study has several limitations. First, the sample size of our study was small, and most patients presented with mild illness. Therefore, the findings may not be extended in patients with a severe disease. Second, CT images of one patient were acquired with 5-mm slice thickness, which might influence the precision of lesion evaluation. Third, due to limited data availability, it is impossible to assess the relationship between CT features and other clinical data, and continued observations of the disease course are needed. Our results of lung abnormalities in the natural history of 36 COVID-19 patients with mild symptoms showed that there was a correlation of disease severity in chest CT findings with the duration of symptoms, especially fever, and that lymphopenia might be a marker of exacerbations of COVID-19. References A Bernheim , XY Mei , MQ Huang , 等 . Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection . Radiology, online , 2020 . DOI: 10.1148/radiol.2020200463 http://doi.org/10.1148/radiol.2020200463 . Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection NS Chen , M Zhou , X Dong , 等 . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study . Lancet , 2020 . 395 ( 10223 ): 507 - 513 . 32007143 DOI: 10.1016/S0140-6736(20)30211-7 http://doi.org/10.1016/S0140-6736(20)30211-7 . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study M Chung , A Bernheim , XY Mei , 等 . CT imaging features of 2019 novel coronavirus (2019-nCoV) . Radiology , 2020 . 295 ( 1 ): 200230 DOI: 10.1148/radiol.2020200230 http://doi.org/10.1148/radiol.2020200230 . CT imaging features of 2019 novel coronavirus (2019-nCoV) WJ Guan , ZY Ni , Y Hu , 等 . Clinical characteristics of coronavirus disease 2019 in China . N Engl J Med , 2020 . 382 ( 18 ): 1708 - 1720 . 32109013 DOI: 10.1056/NEJMoa2002032 http://doi.org/10.1056/NEJMoa2002032 . Clinical characteristics of coronavirus disease 2019 in China CL Huang , YM Wang , XW Li , 等 . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China . Lancet , 2020 . 395 ( 10223 ): 497 - 506 . 31986264 DOI: 10.1016/S0140-6736(20)30183-5 http://doi.org/10.1016/S0140-6736(20)30183-5 . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China RJ Lu , X Zhao , J Li , 等 . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding . Lancet , 2020 . 395 ( 10224 ): 565 - 574 . 32007145 DOI: 10.1016/S0140-6736(20)30251-8 http://doi.org/10.1016/S0140-6736(20)30251-8 . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding CGC Ooi , PL Khong , B Lam , 等 . Severe acute respiratory syndrome: relationship between radiologic and clinical parameters . Radiology , 2003 . 229 ( 2 ): 492 - 499 . 14526098 DOI: 10.1148/radiol.2292030736 http://doi.org/10.1148/radiol.2292030736 . Severe acute respiratory syndrome: relationship between radiologic and clinical parameters F Pan , TH Ye , P Sun , 等 . Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia . Radiology, online , 2020 . DOI: 10.1148/radiol.2020200370 http://doi.org/10.1148/radiol.2020200370 . Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia YY Pan , HX Guan , SC Zhou , 等 . Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China . Eur Radiol, Online , 2020 . DOI: 10.1007/s00330-020-06731-x http://doi.org/10.1007/s00330-020-06731-x . Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China HS Shi , XY Han , NC Jiang , 等 . Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study . Lancet , 2020 . 20 ( 4 ): 425 - 434 . 32105637 DOI: 10.1016/S1473-3099(20)30086-4 http://doi.org/10.1016/S1473-3099(20)30086-4 . Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study FX Song , NN Shi , F Shan , 等 . Emerging 2019 novel coronavirus (2019-nCoV) pneumonia . Radiology , 2020 . 295 ( 1 ): 200274 DOI: 10.1148/radiol.2020200274 http://doi.org/10.1148/radiol.2020200274 . Emerging 2019 novel coronavirus (2019-nCoV) pneumonia DW Wang , B Hu , C Hu , 等 . Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China . JAMA , 2020 . 323 ( 11 ): 1061 - 1069 . DOI: 10.1001/jama.2020.1585 http://doi.org/10.1001/jama.2020.1585 . Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China J Wu , XJ Wu , WB Zeng , 等 . Chest CT findings in patients with coronavirus disease 2019 and its relationship with clinical features . Invest Radiol , 2020 . 55 ( 5 ): 257 - 261 . 32091414 DOI: 10.1097/rli.0000000000000670 http://doi.org/10.1097/rli.0000000000000670 . Chest CT findings in patients with coronavirus disease 2019 and its relationship with clinical features ZY Wu , JM McGoogan . Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention . JAMA , 2020 . 323 ( 13 ): 1239 - 1242 . DOI: 10.1001/jama.2020.2648 http://doi.org/10.1001/jama.2020.2648 . Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention Z Xu , L Shi , YJ Wang , 等 . Pathological findings of COVID-19 associated with acute respiratory distress syndrome . Lancet Respir Med , 2020 . 8 ( 4 ): 420 - 422 . 32085846 DOI: 10.1016/S2213-2600(20)30076-X http://doi.org/10.1016/S2213-2600(20)30076-X . Pathological findings of COVID-19 associated with acute respiratory distress syndrome YD Yin , RG Wunderink . MERS, SARS and other coronaviruses as causes of pneumonia . Respirology , 2018 . 23 ( 2 ): 130 - 137 . 29052924 DOI: 10.1111/resp.13196 http://doi.org/10.1111/resp.13196 . MERS, SARS and other coronaviruses as causes of pneumonia ZY Zu , MD Jiang , PP Xu , 等 . Coronavirus disease 2019 (COVID-19): a perspective from China . Radiology, online , 2020 . DOI: 10.1148/radiol.2020200490 http://doi.org/10.1148/radiol.2020200490 . Coronavirus disease 2019 (COVID-19): a perspective from China Compliance with ethics guidelines Zhu-jing SHEN, Nan LU, Lu-lu GAO, Jian LV, Hua-fu LUO, Ji-feng JIANG, Chao XU, Shi-ya LI, Ju-jiang MAO, Kai LI, Xiao-pei XU, and Bin LIN declare that they have no conflict of interest. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). Local institutional review boards approved the protocol. Due to the urgency of distributing these findings, the institutional review board of the Second Affiliated Hospital, Zhejiang University School of Medicine (Hangzhou, China) waived the necessity to get consent for the collection, analysis, and publication of these patients’ data. 10.1631/jzus.B2000133 Project supported by the Zhejiang University Special Scientific Research Fund for COVID-19 Prevention and Control (No. 2020XGZX036), China 2020-03-23 2020-05-02 2022-01-05 Copyright © Zhejiang University and Springer-Verlag GmbH Germany, part of Springer Nature 2020 2020 Journal of Zhejiang University-SCIENCE B (Biomedicine and Biotechnology) 08 21